Question

Difficulty: HardReproductive Endocrinology and Infertility

A 26-year-old woman is evaluated in the office alongside her husband due to primary infertility. The couple has engaged in regular, unprotected vaginal intercourse for the past 16 months without achieving pregnancy. The patient reports that her menstrual periods are highly unpredictable, typically occurring at 60- to 90-day intervals. Over the last three years, she has noticed the gradual onset of coarse, dark hair growing on her upper lip and chin, which she manages by daily plucking. She has no chronic medical conditions and takes no medications other than a prenatal vitamin. Vital signs are within normal limits. Her body mass index is 29 kg/m229 \text{ kg/m}^2. Physical examination demonstrates a female escutcheon and normal external genitalia without clitoromegaly. A bimanual pelvic examination is unremarkable. The partner's semen analysis parameters are within normal reference ranges. A transvaginal ultrasound reveals bilaterally enlarged ovaries, each containing 15 to 20 small, peripherally oriented follicles. Serum concentrations of prolactin and thyroid-stimulating hormone are normal. The clinician suspects polycystic ovary syndrome (PCOS). To definitively establish this diagnosis, which of the following is the most appropriate next step in the laboratory evaluation?

  1. Basal serum 17-hydroxyprogesterone concentrationAnswer
  2. B
    Serum anti-Müllerian hormone concentration
  3. C
    Initiation of letrozole therapy
  4. D
    Serum dehydroepiandrosterone sulfate concentration
  5. E
    Fasting serum insulin concentration

Answer

Basal serum 17-hydroxyprogesterone concentration
The patient presents with clinical hyperandrogenism, oligo-ovulation, and polycystic ovaries on transvaginal ultrasound. While these findings satisfy the Rotterdam criteria for polycystic ovary syndrome (PCOS), PCOS remains a diagnosis of exclusion. Non-classic congenital adrenal hyperplasia (NCAH), primarily due to partial 21-hydroxylase deficiency, can present with identical clinical, metabolic, and sonographic findings. Therefore, authoritative guidelines mandate screening all women with suspected PCOS for NCAH by measuring an early morning (basal) 17-hydroxyprogesterone concentration. If the level is elevated, an ACTH stimulation test is performed to confirm NCAH.

Step-by-Step Solution

1
Identify the primary clinical presentation.
The patient has oligo-ovulation (irregular menses), clinical hyperandrogenism (hirsutism), and polycystic ovaries on ultrasound.
These three findings satisfy the Rotterdam criteria, making polycystic ovary syndrome (PCOS) the most likely diagnosis.
2
Recognize the diagnostic requirement for PCOS.
PCOS is strictly a diagnosis of exclusion.
Other endocrinopathies that cause hyperandrogenism and anovulation must be biochemically ruled out before confirming PCOS.
3
Determine the necessary screening test based on the patient's presentation.
The patient requires screening for non-classic congenital adrenal hyperplasia (NCAH) using a basal 17-hydroxyprogesterone level.
NCAH caused by 21-hydroxylase deficiency can perfectly mimic the clinical and sonographic features of PCOS without causing severe virilization.

Key Concept

Polycystic ovary syndrome (PCOS) is a diagnosis of exclusion; all patients with suspected PCOS must be screened for non-classic congenital adrenal hyperplasia (NCAH) using a basal early morning 17-hydroxyprogesterone concentration.
Rate this question